Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cobamamide in malnourished patients
NCT05944744Unknown
- Sponsor
- Faculty of Medicine, Universitas Indonesia
- Start
- Jul 2023
- Primary completion
- Jul 2024
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Randomised, double-blind trial of adenosylcobalamin in Malnutrition, sponsored by Faculty of Medicine, Universitas Indonesia. Primary endpoints: Change of Appetite at 28 days, Nutritional Status at 28 days and 1 more. Status: unknown.
02
Drugs
adenosylcobalamin
03
Conditions
Malnutrition
Beyond the preview
Go deeper on NCT05944744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05944744.